Company news

Huons Global Co., Ltd. news in 2025

Huons Global Co., Ltd.'s news releases, calls and decks from 2025, newest first.

Huonslab Secures Formulation Patent for Recombinant Human Hyaluronidase Product, HYDIZYME™

July 23, 2025

Huonslab Achieves Last-Patient-In (LPI) in Phase 1 Pivotal Study for Recombinant Human Natural Hyaluronidase PH20

May 26, 2025

Decks in 2025

Q1 2025 Earnings Presentation
Earnings · 19 slides · 2025